Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Diseases × Everolimus × Clear all

Sponsor

Conditions

Breast Neoplasms 34 Carcinoma, Renal Cell 29 Neoplasms 17 Kidney Neoplasms 15 Neuroendocrine Tumors 13 Neoplasm Metastasis 12 Tuberous Sclerosis 8 Prostatic Neoplasms 8 Carcinoma 8 Lymphoma, Mantle-Cell 7 Hodgkin Disease 7 Waldenstrom Macroglobulinemia 6 Recurrence 6 Lymphoma, Large B-Cell, Diffuse 6 Head and Neck Neoplasms 6 Glioma 6 Triple Negative Breast Neoplasms 5 Ovarian Neoplasms 5 Lymphoma 5 Glioblastoma 5 Colorectal Neoplasms 5 Carcinoma, Neuroendocrine 5 Brain Neoplasms 5 Astrocytoma 5 Sezary Syndrome 4 Sarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Mycosis Fungoides 4 Melanoma 4

Interventions

Sorafenib 2 vandetanib 1 temsirolimus 1 selpercatinib 1 pralsetinib 1 lenvatinib 1 cabozantinib 1 Vitamin B 12 1 Thyrotropin-Releasing Hormone 1 Technetium Tc 99m Sestamibi 1 Pemetrexed 1 Panobinostat 1 NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt 1 Metformin 1 Folic Acid 1 Cisplatin 1 Cetuximab 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡